Beauchamp, Norma

Track

Insider profile

Performance

Overall performance
1.5
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -20% 8.2% 15.1%
Success rate 15% 68% 82%
Transactions
4 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -24%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Beauchamp, Norma's trades of HLS Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
352.20
Quantity 91,698
Value CA$2,431,037
Transaction date
Sale
Price
473.63
Quantity 46,974
Value CA$1,426,184
Transaction date
Sale
Price
474.08
Quantity 78,554
Value CA$1,059,181
Transaction date
Purchase
Price
0.80
Quantity 4,905 +189.0%
Value CA$3,924
Transaction date
Sale
Price
2.06
Quantity 43 -1.6%
Value CA$89
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-27 2024-12-24
B Purchase
91,698
352.20
CA$2,431,037 		91,698 352.20 CA$2,431,037
2024-11-14 2024-11-14
S Sale
46,974
473.63
CA$1,426,184 		46,974 473.63 CA$1,426,184
2023-09-03 2023-08-29
S Sale
78,554
474.08
CA$1,059,181 		78,554 474.08 CA$1,059,181
2023-06-26 2023-06-23
B Purchase
4,905 +189.0%
0.80
CA$3,924 		4,905 +189.0% 0.80 CA$3,924
2022-11-20 2022-11-15
S Sale
43 -1.6%
2.06
CA$89 		43 -1.6% 2.06 CA$89
2022-05-25 2022-05-25
S Sale
5,837 -23.3%
4.16
CA$24,282 		5,837 -23.3% 4.16 CA$24,282